Predictive Factors for Prolonged Urination Disorder After Permanent 125I Brachytherapy for Localized Prostate Cancer

In Vivo. 2017 Jul-Aug;31(4):755-761. doi: 10.21873/invivo.11127.

Abstract

Background: We assessed the change in LUTS after prostate brachytherapy to reveal factors for prolonged urination disorder.

Materials and methods: Four hundred and four patients received prostate brachytherapy at our institution and were followed-up for at least 2 years. We evaluated the correlation of mean IPSS changes and clinical factors. Using multivariate analysis, we also evaluated clinical factors with potential to delay IPSS resolution.

Results: In cases with prostate volume more than 30 cm3, radiation dose to 90% of prostate volume (D90) more than 160 Gy, and radiation dose to 30% of the urethral volume (UD30) more than 240 Gy, mean IPSS levels were significantly higher, even 30 months after treatment. On multivariate analysis, baseline IPSS more than 8 points and D90 more than 160 Gy were significant predictors for delayed IPSS resolution.

Conclusion: Our data suggest that higher baseline IPSS and higher D90 were predictors for prolonged urination disorder.

Keywords: Brachytherapy; lower urinary tract symptoms; prostate cancer.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brachytherapy / adverse effects*
  • Humans
  • Iodine Radioisotopes / administration & dosage
  • Iodine Radioisotopes / adverse effects
  • Male
  • Middle Aged
  • Prostate / pathology
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Urination Disorders / blood
  • Urination Disorders / etiology
  • Urination Disorders / pathology*

Substances

  • Iodine Radioisotopes
  • Prostate-Specific Antigen